rs41279055

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_005592.4(MUSK):​c.1931T>C​(p.Val644Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00357 in 1,604,290 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V644L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0027 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0037 ( 15 hom. )

Consequence

MUSK
NM_005592.4 missense

Scores

5
9
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:6

Conservation

PhyloP100: 7.95

Publications

8 publications found
Variant links:
Genes affected
MUSK (HGNC:7525): (muscle associated receptor tyrosine kinase) This gene encodes a muscle-specific tyrosine kinase receptor. The encoded protein may play a role in clustering of the acetylcholine receptor in the postsynaptic neuromuscular junction. Mutations in this gene have been associated with congenital myasthenic syndrome. Alternatively spliced transcript variants have been described.[provided by RefSeq, Oct 2009]
MUSK Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 9
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • fetal akinesia deformation sequence 1
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.057576776).
BP6
Variant 9-110800309-T-C is Benign according to our data. Variant chr9-110800309-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 259805.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00266 (404/151880) while in subpopulation SAS AF = 0.00461 (22/4772). AF 95% confidence interval is 0.00363. There are 3 homozygotes in GnomAd4. There are 216 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MUSKNM_005592.4 linkc.1931T>C p.Val644Ala missense_variant Exon 15 of 15 ENST00000374448.9 NP_005583.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MUSKENST00000374448.9 linkc.1931T>C p.Val644Ala missense_variant Exon 15 of 15 5 NM_005592.4 ENSP00000363571.4
MUSKENST00000416899.7 linkc.1907T>C p.Val636Ala missense_variant Exon 14 of 14 5 ENSP00000393608.3
MUSKENST00000189978.10 linkc.1673T>C p.Val558Ala missense_variant Exon 14 of 14 5 ENSP00000189978.6

Frequencies

GnomAD3 genomes
AF:
0.00266
AC:
404
AN:
151762
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000388
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00321
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00461
Gnomad FIN
AF:
0.00274
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00402
Gnomad OTH
AF:
0.00336
GnomAD2 exomes
AF:
0.00298
AC:
730
AN:
245278
AF XY:
0.00322
show subpopulations
Gnomad AFR exome
AF:
0.000259
Gnomad AMR exome
AF:
0.00158
Gnomad ASJ exome
AF:
0.00145
Gnomad EAS exome
AF:
0.0000557
Gnomad FIN exome
AF:
0.00269
Gnomad NFE exome
AF:
0.00427
Gnomad OTH exome
AF:
0.00268
GnomAD4 exome
AF:
0.00367
AC:
5329
AN:
1452410
Hom.:
15
Cov.:
32
AF XY:
0.00364
AC XY:
2627
AN XY:
720868
show subpopulations
African (AFR)
AF:
0.000330
AC:
11
AN:
33336
American (AMR)
AF:
0.00182
AC:
81
AN:
44400
Ashkenazi Jewish (ASJ)
AF:
0.00160
AC:
41
AN:
25694
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39498
South Asian (SAS)
AF:
0.00351
AC:
300
AN:
85486
European-Finnish (FIN)
AF:
0.00258
AC:
137
AN:
53116
Middle Eastern (MID)
AF:
0.00402
AC:
23
AN:
5722
European-Non Finnish (NFE)
AF:
0.00411
AC:
4545
AN:
1105236
Other (OTH)
AF:
0.00319
AC:
191
AN:
59922
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
253
506
758
1011
1264
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
170
340
510
680
850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00266
AC:
404
AN:
151880
Hom.:
3
Cov.:
32
AF XY:
0.00291
AC XY:
216
AN XY:
74248
show subpopulations
African (AFR)
AF:
0.000386
AC:
16
AN:
41408
American (AMR)
AF:
0.00321
AC:
49
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5156
South Asian (SAS)
AF:
0.00461
AC:
22
AN:
4772
European-Finnish (FIN)
AF:
0.00274
AC:
29
AN:
10592
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00402
AC:
273
AN:
67904
Other (OTH)
AF:
0.00332
AC:
7
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
22
44
67
89
111
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00357
Hom.:
1
Bravo
AF:
0.00284
TwinsUK
AF:
0.00189
AC:
7
ALSPAC
AF:
0.00285
AC:
11
ESP6500AA
AF:
0.000481
AC:
2
ESP6500EA
AF:
0.00344
AC:
29
ExAC
AF:
0.00273
AC:
330
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:3
May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MUSK: BS2 -

Mar 22, 2021
Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BS1 -

Jun 29, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 25, 2015
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 08, 2016
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital myasthenic syndrome 9 Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Fetal akinesia deformation sequence 1;C4225368:Congenital myasthenic syndrome 9 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.68
BayesDel_addAF
Benign
0.0069
T
BayesDel_noAF
Pathogenic
0.24
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.48
T;.;.;.
Eigen
Uncertain
0.22
Eigen_PC
Uncertain
0.29
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.77
T;T;T;T
M_CAP
Uncertain
0.097
D
MetaRNN
Benign
0.058
T;T;T;T
MetaSVM
Uncertain
-0.068
T
MutationAssessor
Benign
1.4
L;.;.;.
PhyloP100
8.0
PrimateAI
Pathogenic
0.80
T
PROVEAN
Uncertain
-3.7
D;.;.;.
REVEL
Pathogenic
0.81
Sift
Uncertain
0.0020
D;.;.;.
Sift4G
Uncertain
0.0030
D;D;D;D
Polyphen
0.37
B;.;.;.
Vest4
0.87
MVP
0.85
MPC
0.76
ClinPred
0.036
T
GERP RS
5.1
Varity_R
0.58
gMVP
0.69
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41279055; hg19: chr9-113562589; COSMIC: COSV105851562; API